CD4 T cells can develop different response programmes. Signals, gene activity and measured function help describe a programme; a single marker does not establish what the cell does.
CD4 T-cell subsets are differentiation programmes shaped by antigen recognition, cytokines and gene regulation. Conventional naive CD4 cells recognize peptide-HLA class II during priming, often on dendritic cells. Th1, Th2, Th17, follicular helper and regulatory programmes have characteristic signals, transcription factors and outputs, but these are not permanent job titles or mutually exclusive functional tests. The original Th1/Th2 distinction came from mouse clones in 1986; human tissue can contain mixed programmes.
CD4 help can improve the magnitude and quality of a CD8 response. Bennett’s experiments showed that CD40 signalling on antigen-presenting cells could replace CD4 help in a defined cross-priming system. Cella found that CD40 ligation increased dendritic-cell IL-12, ICAM-1, CD80 and CD86 and their T-cell-stimulating capacity. These support one licensing mechanism, not a requirement that every response follows an identical route.
Alspach’s mouse-tumour work required tumour-antigen-specific CD4 and CD8 responses even when the cancer cells lacked class-II molecules; tumour expression of class-II-restricted antigens was needed at the successful rejection site. In Ott’s phase-I melanoma vaccine trial, six people received personal neoantigens. CD4 responses targeted 58 of 97 neoantigens (60%) and CD8 responses 15 (16%). Four of six had no recurrence at 25 months, but the small uncontrolled study did not isolate clinical efficacy.
In untreated human breast tumours, Gu-Trantien found CXCL13-producing Tfh cells mainly in tertiary-lymphoid-structure germinal centres and an eight-gene signature associated with survival or preoperative-chemotherapy response. That is a prognostic association. DeNardo’s mouse mammary-cancer experiments showed a different possibility: IL-4-producing CD4 cells shaped macrophages that promoted invasion and lung metastasis. Subset identity therefore needs tissue, timing and measured-function context.
In plain words · CD4 helps identify a major T-cell population. Those cells can support, restrain or, in some settings, directly kill other cells.
Showing the target this term concerns: CD4.
Shares CD4, Tertiary lymphoid structures (TLS).
Shares Regulatory T cells, T cell.
Shares Agretopicity, Adaptive immune resistance, Tumour-infiltrating lymphocytes (TILs).
Shares Agretopicity, Neoantigen, Personalised neoantigen (mRNA) vaccines.
Shares CD40, Tumour-associated macrophages (TAMs).
Shares Neoantigen, The cancer-immunity cycle, Personalised neoantigen (mRNA) vaccines.
Shares CD40, Tumour-associated macrophages (TAMs).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/